Clinical trial process for sickle cell disease gene therapy - Nicole Farmer @genometv
Clinical trial process for sickle cell disease gene therapy - Nicole Farmer  @genometv
Uploaded September 2024 | Updated September 2026, 7 hours ago
Gene therapy for sickle cell disease is available to you through FDA-approved therapies (lovotibeglogene autotemcel and exagamglogene autotemcel), and through clinical trials. While there are a number of clinical trials for sickle cell gene therapy, the journey can be similar across all treatments.

Nicole Farmer, M.D., Staff Scientist at the NIH Clinical Center, explains that seeking the right therapy is a long process and how it is important to understand what happens at each step. Talk with your healthcare team before, during and after each step.

About the: Sickle cell disease gene therapy education project: genome.gov/research-at-nhgri/Projects/Democratizing-Education

Lovotibeglogene autotemcel Injection: medlineplus.gov/druginfo/meds/a624020.html
Exagamglogene autotemcel: medlineplus.gov/druginfo/meds/a624020.html
Gene Therapy for Sickle Cell Disease through Clinical Trials: clinicaltrials.gov/search?term=%22gene%20therapy%22&cond=Sickle%20Cell%20Disease&country=United%20States&locStr=United%20States&viewType=Table#classicRedirect
Clinical trial process for sickle cell disease gene therapy - Nicole FarmerSBRB Seminar Series - Anita KinneyDNA Origami Challenge: Eric Vs. Cardboard EricNACHGR Director Report (May 2024) - Eric GreenRFA: Genomics Research to Elucidate the Genetics of Rare Disease (GREGoR) Renewal  - Lisa ChadwickWay Cool Genomics: Octopus RNA editors! #waycoolgenomics #science #rna #octopus #comparativegenomicsInformational Session on the Renewed ELSI Funding Opportunities60 questions with NHGRI director Eric GreenPRS for the PCP: Evaluating polygenic risk scoring in primary care with clinical trialsGenomic Data Science Working Group of Council Annual Report - Shannon McWeeney and Anshul KundajeJourneys in Human Genetics and Genomics Colloquium -  Adam Phillippy2024 Three-minute Talk (TmT) - Tara Desporte, Postbac, NHGRI
National Human Genome Research Institute |

Clinical trial process for sickle cell disease gene therapy - Nicole Farmer

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER